Evolent Health, Inc.
EVHHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeEvolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. Valued at $444.3M, EVH is a small-cap name in its sector. The company offers integrated value-based care platform for health plan administration and management.
Market Cap
$444.3M
Beta
0.83
P/E (TTM)
—
P/E (Fwd)
9.78
EPS (TTM)
$-4.68
EPS (Fwd)
$0.40
ROE
-65.1%
ROA
-0.4%
Cash
$142.0M
Total Debt
$985.4M
Free CF
$52.9M
52W Change
-47.8%
Annual Financials
Cash vs Debt
The company holds $142.0M in cash, though total debt stands at $985.4M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $52.9M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of -65.1% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $1.35B (2022) to $1.88B (2025), reflecting a 39% increase over the period.
The debt-to-cash ratio suggests meaningful leverage on the balance sheet, a factor worth monitoring if credit conditions tighten. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Evolent Health, Inc.'s trajectory.